70452-33-4 Usage
Uses
Used in Pharmaceutical Industry:
Tryptanthrin is utilized as a potential therapeutic agent for its anti-inflammatory properties, serving to reduce inflammation by suppressing the production of pro-inflammatory molecules. This makes it a candidate for the treatment of various inflammatory conditions.
Used in Anticancer Applications:
In the field of oncology, tryptanthrin is employed as an anticancer agent, demonstrating its ability to inhibit the growth of various cancer cells. Its potential to target multiple types of cancer cells positions it as a compound worth investigating for the development of novel cancer treatments.
Used in Antimicrobial Applications:
Tryptanthrin also serves as an antimicrobial agent, showing potential to inhibit the activity of certain bacterial and fungal strains. This makes it a candidate for use in the development of new antibiotics and antifungal medications, particularly in the context of increasing antibiotic resistance.
Used in Drug Research and Development:
Due to its diverse pharmacological properties, tryptanthrin is used in drug research and development as a compound of interest for the creation of new medications targeting inflammation, cancer, and infectious diseases. Its potential applications span across various medical fields, making it a valuable asset in pharmaceutical innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 70452-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,4,5 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 70452-33:
(7*7)+(6*0)+(5*4)+(4*5)+(3*2)+(2*3)+(1*3)=104
104 % 10 = 4
So 70452-33-4 is a valid CAS Registry Number.
70452-33-4Relevant academic research and scientific papers
Synthesis, spectroscopic characterization, and in vitro antimicrobial potency of sulfur-bonded complexes of boron(III)
Swami, Monika,Mahajan, Karuna,Gupta, Neeti,Singh,Arya, Sunita,Kushwah, Sonalika
experimental part, p. 2125 - 2139 (2010/02/28)
The present article describes the synthesis and characterization of tetracoordinated boron (III) complexes with monobasic bidentate ligands (L 1H, L2H, L3H, L4H, L5H, and L6H) having the ge
